Invention Grant
- Patent Title: Oral formulations and lipophilic salts of methylnaltrexone
-
Application No.: US16219681Application Date: 2018-12-13
-
Publication No.: US10307417B2Publication Date: 2019-06-04
- Inventor: Syed M. Shah , Christopher Richard Diorio , Eric C. Ehrnsperger , Xu Meng , Kadum A. Al Shareffi , Jonathan Marc Cohen
- Applicant: Wyeth, LLC
- Applicant Address: US NJ Madison
- Assignee: Wyeth, LLC
- Current Assignee: Wyeth, LLC
- Current Assignee Address: US NJ Madison
- Agency: McCarter & English, LLP
- Agent Jonathan M. Sparks; Maneesh Gulati, Esq.
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K9/20 ; C07D489/08 ; A61K9/00 ; A61K47/20 ; A61K47/12 ; A61K9/28
Abstract:
The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
Public/Granted literature
- US20190117646A1 ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE Public/Granted day:2019-04-25
Information query
IPC分类:
